Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer.
The place of CA 72-4, a new tumor marker in the prognosis of stomach cancer were studied, Endoscopically and histologically diagnosed 47 gastric patients were studied. CEA, CA 19-9, CA 125, CA 15-3, CA 72-4 levels were measured. We determined that serum CA 72-4 level in the group with cancer was significantly elevated. In patients particularly having liver metastases, CA 72-4 level was found to be greater. We are of the opinion that serum CA 72-4 level is a valuable parameter in the prognosis of stomach cancer.